Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zhongyuan Union Stem Cell Bioengineering Co appoints chairman and general manager


Friday, 7 Feb 2014 07:00pm EST 

Zhongyuan Union Stem Cell Bioengineering Co:Appoints Li Defu as chairman of the board and Wu Mingyuan as general manager of the company, effective Feb. 8. 

Company Quote